Valbenazine is the first medication approved by the fda for the treatment of adults with td, a spectrum of hyperkinetic movement disorders often associated with antipsychotic therapy. Valbenazine is a medication that is used to decrease the frequency and severity of involuntary, uncontrollable muscle movements that are related to a condition known as tardive dyskinesia (td). Tardive dyskinesia (td) is a medication-induced hyperkinetic movement disorder caused by exposure to dopamine receptor-blocking agents, most often antipsychotic drugs, that persists for at least a month …

Movements in the face, tongue, or … Learn about valbenazine medication, its uses for tardive dyskinesia, recommended dosages, side effects, and how it works as a vmat2 inhibitor to manage movement disorders. In contrast, for tardive dyskinesia, the american psychiatric association (apa) and american academy of neurology (aan) guidelines recommend reversible vmat2 inhibitorsâ€valbenazine or …